Claudication
41
7
7
25
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.8%
4 terminated out of 41 trials
86.2%
-0.3% vs benchmark
7%
3 trials in Phase 3/4
28%
7 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (41)
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery
Neurostimulation in Intermittent Claudication
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Clinical Interest of the TcPO2 Technique
ILLUMENATE EU Randomized Clinical Trial
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Validation of a Treadmill Walking Test to Discriminate Neurogenic Claudication From Vascular Claudication
RECCORD (Recording Courses of Vascular Diseases) Registry
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems
Patient and Provider Assessment of Lipid Management Registry
Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries
Peripheral Vascular Disease and Nerve Stimulation
Study of SilverHawk®/TurboHawk® in Lower Extremity Vessels (DEFINITIVE™ LE)